rs199751225
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP6BS1
The NM_020919.4(ALS2):āc.4964A>Cā(p.Lys1655Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000911 in 1,613,794 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020919.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000427 AC: 65AN: 152062Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000105 AC: 26AN: 248180Hom.: 0 AF XY: 0.0000965 AC XY: 13AN XY: 134744
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461614Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 727110
GnomAD4 genome AF: 0.000434 AC: 66AN: 152180Hom.: 1 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.4964A>C (p.K1655T) alteration is located in exon 34 (coding exon 33) of the ALS2 gene. This alteration results from a A to C substitution at nucleotide position 4964, causing the lysine (K) at amino acid position 1655 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Infantile-onset ascending hereditary spastic paralysis Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at